Helping to Meet the Needs of the Changing Healthcare Environment

Press Releases

• Monday, July 26, 2021

  Aesculap Implant Systems Announces the Long-Term Reporting from its Pivotal IDE Trial for the activL® Artificial Disc

  Read More
• Tuesday, July 7, 2020

  Aesculap Implant Systems Announces New Positive Third-Party Clinical Guidelines that May Introduce Access for More than 8.5 Million Commercially Insured Americans to the activL® Artificial Disc

  Read More
• Thursday, June 18, 2020

  Aesculap Celebrates Five-Year Anniversary of the FDA Approval of the activL Artificial Disc: Five Years and Five Milestones

  Read More